Objective: The clinical cases of patients with multisystem inflammatory syndrome (MIS-C)
were analyzed via a systematic review and meta-analysis of the clinical findings, treatments …

Children less than 18 years of age account for an estimated 2%–5% of reported severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) cases globally. Lower prevalence …

To conduct a systematic review and meta‐analysis to characterize inflammatory markers in
comparisons of multisystem inflammatory syndrome in children (MIS‐C) versus severe/non …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Objective To describe the clinical, laboratory, and radiological characteristics, as well as the
outcomes of children with MIS-C. Method Multicenter, prospective cohort study, conducted in …

Background This study provides the first systematic review and meta-analysis to identify the
predictors of unfavorable prognosis of COVID-19 in children and adolescents. Methods We …

Abstract Purpose of Review In this article, I have reviewed current reports that explore
differences and similarities between multisystem inflammatory syndrome in children (MIS-C) …

The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the
pathogen responsible for Coronavirus Disease 2019 (COVID-19). Whilst most children and …

Objective A meta-analysis of laboratory cardiac markers for multisystem inflammatory
syndrome in children (MIS-C) was performed in patients with coronavirus disease 2019 …

OBJECTIVES: To prospectively evaluate demographic, anthropometric and health-related
quality of life (HRQoL) in pediatric patients with laboratory-confirmed coronavirus disease …